0 Kommentare
0 Geteilt
1467 Ansichten
0 Bewertungen
Search
Entdecken Sie neue Leute, neue Verbindungen zu schaffen und neue Freundschaften
- Bitte melde dich an, um zu liken, Beiträge zu teilen und Kommentare zu hinterlassen!
- Diagnostic Exosome Biomarkers Market Size, Overview, Share and ForecastThe Diagnostic Exosome Biomarkers Market in 2023 is US$ 196.8 Million, and is expected to reach US$ 668.69 Million by 2031 at a CAGR of 16.50%. FutureWise Research published a report that analyzes Diagnostic Exosome Biomarkers Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure....0 Kommentare 0 Geteilt 1121 Ansichten 0 Bewertungen
- Global Renal Biomarkers Market Is Estimated To Witness High Growth Owing To Increasing Incidence of Kidney Diseases and Growing Demand for Non-invasive Diagnostic TechniquesThe Renal Biomarkers Market is estimated to be valued at US$ 1,476.2 million in 2021 and is expected to exhibit a CAGR of 8.2% over the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.Market Overview:The Renal Biomarkers Market focuses on the development and commercialization of biomarkers that can be used for the early detection and diagnosis...0 Kommentare 0 Geteilt 1818 Ansichten 0 Bewertungen
- Neurological Biomarkers Market: Rising Demand for Diagnostic Tools and Innovative TherapiesMarket Overview:The neurological biomarkers market is estimated to be valued at US$ 8,979.6 Mn in 2023 and is projected to witness a remarkable growth rate, with a CAGR of 14.7% during the forecast period 2023-2030. Neurological biomarkers are biological indicators that provide insights into the presence and progression of neurological diseases. These biomarkers play a crucial role in the...0 Kommentare 0 Geteilt 1538 Ansichten 0 Bewertungen
- Biomarkers: Unraveling the Significance of Molecular Markers in Precise Disease DiagnosisWhat are Biomarkers?Biological maker are molecules found in blood, other body fluids, or tissues that are indicators of a normal or abnormal process, or of a condition or disease. These molecules may be produced by the body in response to the presence of a disease or they may be the byproduct of the disease process itself. By measuring specific biological maker, doctors and researchers can gain...0 Kommentare 0 Geteilt 439 Ansichten 0 Bewertungen
- Cancer Biomarkers Market Expected to Grow at a Significant Pace owing to Rising Incidence of Cancer CasesMarket Overview:Cancer biomarkers are biological molecules found in blood, urine, other body fluids or tissues that are indicators of normal or abnormal biological processes, pathogenic processes, or pharmacological responses to therapeutic interventions. Cancer biomarkers play a vital role in cancer diagnosis, prognosis, targeted therapy and monitoring treatment effectiveness or recurrence of...0 Kommentare 0 Geteilt 1481 Ansichten 0 Bewertungen
- Circulating Cell-Free Tumor DNA: A Potential Breakthrough for Early Cancer Detection and TreatmentCancer begins with genetic changes inside cells that cause them to grow and divide uncontrollably. As tumors grow, cells are continuously dying off and releasing DNA into the bloodstream. This circulating cell-free DNA (cfDNA) contains genetic mutations from the original tumor. Recent advances have enabled the detection and analysis of this circulating tumor DNA (ctDNA) and opened up new...0 Kommentare 0 Geteilt 1293 Ansichten 0 Bewertungen
- Global Companion Diagnostic Market Set to Expand to US$ 32340 million by 2030 at 20.3 CAGRPragma Market Research and Business Consulting has published a new study titled "Companion Diagnostic Market: Size, Trends, and Insights" covering the market's dimensions, trends, and insights. Market Overview “According to the latest research study, the demand of global Companion Diagnostic Market size & share was valued at approximately US$ 8820 million in 2023 and is expected to...0 Kommentare 0 Geteilt 747 Ansichten 0 Bewertungen
- PARP Inhibitor Biomarkers Market Are Estimated To Witness High Growth Owing To Rising Demand As Companion DiagnosticsPARP (Poly ADP-Ribose Polymerase) inhibitor biomarkers are used for the stratification of patients with certain cancers like breast and ovarian cancer into those likely to respond to PARP inhibitor treatment and those unlikely to respond. They play an important role as companion diagnostics alongside PARP inhibitors drugs to identify patients with homologous recombination deficiency (HRD)...0 Kommentare 0 Geteilt 1185 Ansichten 0 Bewertungen